查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲 dPCR 和 qPCR 市场预测至 2030 年 - 区域分析 - 按处理、产品、应用和最终用户
市场调查报告书
商品编码
1494311

欧洲 dPCR 和 qPCR 市场预测至 2030 年 - 区域分析 - 按处理、产品、应用和最终用户

Europe dPCR and qPCR Market Forecast to 2030 - Regional Analysis - By Treatment, Product, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 107 Pages | 订单完成后即时交付

价格

2022年欧洲dPCR和qPCR市值为25.7383亿美元，预计2030年将达到51.8296亿美元；预计 2022 年至 2030 年复合年增长率为 9.1%。

遗传性疾病和传染病发病率的增加推动了欧洲 dPCR 和 qPCR 市场

根据国家组织关于遗传性疾病或先天性残疾的信息，虽然个体遗传性疾病很少见，但总体而言，被诊断患有遗传性疾病的人超过 15,500 人。 2020 年 6 月，根据诺华公司（瑞士）的报告，约有 15,000 人患有镰状细胞疾病，每年有 270 名新生儿被诊断​​出患有此疾病。 COVID-19 的爆发对聚合酶炼式反应市场的成长产生了重大影响。临床诊断市场不断增长的需求对PCR产业产生了有利的影响。几乎所有诊断测试都使用 RT-PCR 来测试有 COVID-19 症状的人，并且医疗保健专家敦促他们进行诊断测试，而当局尚未认可病毒培养测试。大多数生物技术和製药企业都将精力集中在研发部门，寻找针对 COVID-19 的新化合物或治疗方法。 2022年2月，罗氏将新发表的分子实验室仪器Cobas 5800系统加入其COVID-19 PCR产品组合中，供接受CE认证的国家使用。这些产品包括cobas SARS-CoV-2和甲型/乙型流感检测，以及cobas SARS-CoV-2定性检测。透过在低、中和高容量分子实验室测试需求中提供统一的性能和效率，这些产品拓宽了罗氏诊断的分子产品组合。此外，借助新型紧凑型 Cobas 5800 系统，空间或资源有限的医疗保健组织可以进行全面存取。在由于缺乏资源或空间而无法容纳较大设备的国家或地区，这将带来更好的测试可访问性。因此，可使用 dPCR 和 qPCR 技术进行诊断和治疗的遗传性疾病和传染病的发生率不断增加，支持了欧洲 dPCR 和 qPCR 市场的成长。

欧洲 dPCR 和 qPCR 市场概况

欧洲 dPCR 和 qPCR 市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。政府和私人对高级研究的资助、人工 DNA 合成创新技术的推出以及基于新技术的应用的各种研究的增加可能是推动欧洲这一市场增长的主要因素。此外，各国政府透过激励条款和研发及新生物技术新创企业免税来鼓励创新的努力预计将有利于欧洲 dPCR 和 qPCR 市场在预测年内的成长。然而，英国脱欧对欧盟的影响可能会导致各种联盟、伙伴关係、合资企业和合作的丧失，进而对欧洲 dPCR 和 qPCR 市场产生负面影响。

欧洲 dPCR 和 qPCR 市场收入及 2030 年预测（百万美元）

欧洲 dPCR 和 qPCR 市场区隔

欧洲 dPCR 和 qPCR 市场根据治疗、产品、应用、最终用户和国家进行细分。

根据处理方式，欧洲 dPCR 和 qPCR 市场分为定量 PCR (qPCR) 和数位 PCR (dPCR)。到 2022 年，数位 PCR (dPCR) 领域将占据更大的份额。

依产品划分，欧洲 dPCR 和 qPCR 市场分为试剂和耗材、仪器以及软体和服务。 2022 年，试剂和耗材领域占最大份额。

依应用划分，欧洲 dPCR 和 qPCR 市场分为研究应用、临床应用和法医应用。 2022年，临床应用领域占据最大份额。

按最终用户划分，欧洲 dPCR 和 qPCR 市场分为医院和诊断中心、製药和生物技术公司、研究实验室和学术机构、法医实验室和临床研究组织。 2022 年，医院和诊断中心细分市场占据最大份额。

根据国家/地区，欧洲 dPCR 和 qPCR 市场分为英国、德国、法国、西班牙、义大利和欧洲其他地区。 2022 年，德国主导了欧洲 dPCR 和 qPCR 市场。

Abbott Laboratories、Thermo Fisher Scientific Inc、Takara Bio Inc、Qiagen NV、Standard BioTools Inc、乐普医疗科技北京有限公司、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc 和 Agilent Technologies Inc 在欧洲dPCR 和qPCR 市场运作。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲 dPCR 和 qPCR 市场格局

  • 概述
  • 欧洲PEST分析

第 5 章：欧洲 dPCR 和 qPCR 市场 - 主要产业动态

  • 市场驱动因素
    • 遗传性疾病和传染病的发生率增加
    • 基因合成的投资和资金不断增加
    • PCR 技术的技术进步
  • 市场限制
    • PCR 系统成本高
    • 与 qPCR 相关的技术限制
  • 市场机会
    • 新兴国家越来越多地采用 PCR 方法
  • 未来的趋势
    • 微滴式数位PCR的发展
  • 影响分析：

第 6 章：dPCR 和 qPCR 市场 - 欧洲市场分析

  • 欧洲 dPCR 和 qPCR 市场收入，2022 - 2030

第 7 章：欧洲 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按治疗方式

  • 概述
  • 2022 年和 2030 年欧洲 dPCR 和 qPCR 市场收入份额（按治疗方式）（%）
  • 定量PCR
  • 数位PCR

第 8 章：欧洲 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 2022 年和 2030 年欧洲 dPCR 和 qPCR 市场收入份额（按产品）（%）
  • 试剂及耗材
  • 仪器
  • 软体与服务

第 9 章：欧洲 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按应用

  • 概述
  • 2022 年和 2030 年欧洲 dPCR 和 qPCR 市场收入份额（按应用）（%）
  • 研究应用
  • 临床应用
  • 法医应用

第 10 章：欧洲 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年欧洲 dPCR 和 qPCR 市场收入份额（按最终用户）（%）
  • 医院和诊断中心
  • 製药和生物技术公司
  • 研究实验室和学术机构
  • 法医实验室
  • 临床研究组织

第 11 章：欧洲 dPCR 和 qPCR 市场 - 国家分析

    • 欧洲 dPCR 和 qPCR 市场（按国家）
      • 英国
      • 德国
      • 法国
      • 义大利
      • 西班牙
      • 欧洲其他地区

第 12 章：dPCR 和 qPCR 市场产业格局

  • 概述
  • 欧洲 dPCR 和 qPCR 市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 13 章：公司简介

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • Takara Bio Inc
  • Qiagen NV
  • Standard BioTools Inc
  • Lepu Medical Technology Beijing Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc

第 14 章：附录

Product Code: BMIRE00029879

The Europe dPCR and qPCR market was valued at US$ 2,573.83 million in 2022 and is expected to reach US$ 5,182.96 million by 2030; it is estimated to grow at a CAGR of 9.1% from 2022 to 2030.

Increasing Incidence of Genetic and Infectious Diseases Drive Europe dPCR and qPCR Market

According to the National Organization's information on genetic conditions or congenital disabilities, though individual genetic disorders are rare, collectively, they comprise over 15,500 people diagnosed with genetic disorders. In June 2020, as per Novartis AG (Switzerland) report, ~15,000 individuals have sickle cell disease, and 270 newborns are diagnosed with the condition every year. The COVID-19 outbreak had a significant effect on the polymerase chain reaction market growth. The growing demand in the clinical diagnostic market has a favorable effect on the PCR industry. Nearly all diagnostic tests use RT-PCR to test the people having symptoms of COVID-19 and were urged by healthcare experts to undergo a diagnostic test, while the authorities have not endorsed viral culture tests. The majority of biotech and pharmaceutical businesses were concentrating their efforts on research and development divisions to find novel compounds or therapy approaches for COVID-19. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. These product include the cobas SARS-CoV-2 and influenza A/B tests, as well as the cobas SARS-CoV-2 qualitative test. By offering uniform performance and efficiency across low-, medium--, and high-volume molecular laboratory testing needs, these products broaden the Roche Diagnostics molecular portfolio offering. Additionally, healthcare organizations with limited space or resources can have comprehensive access owing to the new, compact Cobas 5800 System. Better testing accessibility will result from this in nations or settings where larger equipment cannot be accommodated due to a lack of resources or space. Thus, increasing incidence of genetic and infectious diseases in which dPCR and qPCR techniques can be used for diagnosis and treatments support the growth of the Europe dPCR and qPCR market.

Europe dPCR and qPCR Market Overview

The European dPCR and qPCR market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Government and private funding for advanced research, the launch of innovative technologies for artificial DNA synthesis, and an increase in various research for novel technology-based applications are likely to be the major factors driving the growth of this market in Europe. In addition, efforts taken by the national governments to encourage innovation through incentive provisions and tax exemption for R&D and new biotech startups are expected to favor the European dPCR and qPCR market growth over the forecast years. However, the effect of Brexit on the European Union may lead to the loss of various alliances, partnerships, ventures, and collaborations, negatively impacting the European dPCR and qPCR market.

Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

Europe dPCR and qPCR Market Segmentation

The Europe dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the Europe dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the Europe dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the Europe dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the Europe dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the Europe dPCR and qPCR market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe dPCR and qPCR market in 2022.

Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc are some of the leading companies operating in the Europe dPCR and qPCR market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe dPCR and qPCR Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis

5. Europe dPCR and qPCR Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidence of Genetic and Infectious Diseases
    • 5.1.2 Rising Investments and Funds for Gene Synthesis
    • 5.1.3 Technological Advancements in PCR Technologies
  • 5.2 Market Restraints
    • 5.2.1 High Costs of PCR Systems
    • 5.2.2 Technical Limitations Associated with qPCR
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of PCR Methods in Emerging Countries
  • 5.4 Future Trends
    • 5.4.1 Development of Droplet Digital PCR
  • 5.5 Impact Analysis:

6. dPCR and qPCR Market - Europe Market Analysis

  • 6.1 Europe dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

7. Europe dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

  • 7.1 Overview
  • 7.2 Europe dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 7.3 Quantitative PCR
    • 7.3.1 Overview
    • 7.3.2 Quantitative PCR: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Digital PCR
    • 7.4.1 Overview
    • 7.4.2 Digital PCR: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

  • 8.1 Overview
  • 8.2 Europe dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • 8.3 Reagents & Consumables
    • 8.3.1 Overview
    • 8.3.2 Reagents & Consumables: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Instruments
    • 8.4.1 Overview
    • 8.4.2 Instruments: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Software & Services
    • 8.5.1 Overview
    • 8.5.2 Software & Services: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

  • 9.1 Overview
  • 9.2 Europe dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • 9.3 Research Application
    • 9.3.1 Overview
    • 9.3.2 Research Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Clinical Application
    • 9.4.1 Overview
    • 9.4.2 Clinical Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.1 Europe dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
  • 9.5 Forensic Application
    • 9.5.1 Overview
    • 9.5.2 Forensic Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

  • 10.1 Overview
  • 10.2 Europe dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 10.3 Hospitals and Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Diagnostic Centers: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Pharmaceutical and Biotechnology Companies
    • 10.4.1 Overview
    • 10.4.2 Pharmaceutical and Biotechnology Companies: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Research Laboratories and Academic Institutes
    • 10.5.1 Overview
    • 10.5.2 Research Laboratories and Academic Institutes: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Forensic Laboratories
    • 10.6.1 Overview
    • 10.6.2 Forensic Laboratories: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.7 Clinical Research Organizations
    • 10.7.1 Overview
    • 10.7.2 Clinical Research Organizations: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe dPCR and qPCR Market - Country Analysis

    • 11.1.1 Europe dPCR and qPCR Market, by Country
      • 11.1.1.1 UK
        • 11.1.1.1.1 UK: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.1.2 UK: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.1.3 UK: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.1.4 UK: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.1.4.1 UK: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.1.5 UK: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.2 Germany
        • 11.1.1.2.1 Germany: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.2 Germany: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.2.3 Germany: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.2.4 Germany: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.2.4.1 Germany: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.2.5 Germany: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.3 France
        • 11.1.1.3.1 France: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.2 France: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.3.3 France: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.3.4 France: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.3.4.1 France: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.3.5 France: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.4 Italy
        • 11.1.1.4.1 Italy: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.4.2 Italy: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.4.3 Italy: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.4.4 Italy: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.4.4.1 Italy: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.4.5 Italy: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.5 Spain
        • 11.1.1.5.1 Spain: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.5.2 Spain: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.5.3 Spain: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.5.4 Spain: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.5.4.1 Spain: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.5.5 Spain: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.6 Rest of Europe
        • 11.1.1.6.1 Rest of Europe: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.6.2 Rest of Europe: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.6.3 Rest of Europe: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.6.4 Rest of Europe: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.6.4.1 Rest of Europe: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.6.5 Rest of Europe: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

12. dPCR and qPCR Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Europe dPCR and qPCR Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Thermo Fisher Scientific Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Takara Bio Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Qiagen NV
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Standard BioTools Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Lepu Medical Technology Beijing Co Ltd
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 F. Hoffmann-La Roche Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Bio-Rad Laboratories Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Agilent Technologies Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Europe dPCR and qPCR Market Segmentation
  • Table 2. Europe dPCR and qPCR Market, by Clinical Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. UK: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. UK: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. UK: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. UK: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. UK: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Germany: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Germany: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Germany: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Germany: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Germany: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. France: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. France: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. France: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. France: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. France: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Italy: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Italy: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Italy: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Italy: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Italy: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Spain: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Spain: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Spain: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Spain: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Spain: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Rest of Europe: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Rest of Europe: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Rest of Europe: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Rest of Europe: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Rest of Europe: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Recent Organic Growth Strategies in Europe dPCR and qPCR Market
  • Table 34. Recent Inorganic Growth Strategies in the Europe dPCR and qPCR Market
  • Table 35. Glossary of Terms, Europe dPCR and qPCR Market

List Of Figures

  • Figure 1. Europe dPCR and qPCR Market Segmentation, By Country
  • Figure 2. Europe - PEST Analysis
  • Figure 3. Europe dPCR and qPCR Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Europe dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Europe dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • Figure 7. Quantitative PCR: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Digital PCR: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Europe dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • Figure 10. Reagents & Consumables: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Instruments: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Software & Services: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Europe dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 14. Research Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Clinical Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Forensic Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Europe dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • Figure 18. Hospitals and Diagnostic Centers: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Pharmaceutical and Biotechnology Companies: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Research Laboratories and Academic Institutes: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Forensic Laboratories: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Clinical Research Organizations: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Europe dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 24. Europe dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 25. UK: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Germany: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. France: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Italy: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Spain: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Rest of Europe: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Growth Strategies in Europe dPCR and qPCR Market